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Bleeding complications on extracorporeal 
membrane oxygenation (ECMO) are often 
encountered.  In a review of our own series, it was 
found that upper aero digestive tract bleeding was 
common and management was often difficult.
A 66 year-old-female was placed on veno-arterial ECMO
(VA ECMO) for profound cardiogenic shock. On ECMO day
6, a bedside transesophageal echocardiography (TEE)
probe was placed. Oropharyngeal bleeding was noted
immediately after the procedure.
• ENT was consulted and conservative management was
attempted with Oxymetolazone and packing.
• Patient continued to bleed, her hemoglobin count
dropped and she required multiple transfusions. At this
time, the patient’s PTT was in the range of 37-53
seconds and there was no bleeding from any other
source. A decision was made to take the patient to the
operating room.
• By the time this decision was made, the patient had
received 16 units of PRBCs, 50 Units of platelets and
2 units of fresh frozen plasma and the ENT team had
seen the patient over 10 separate times.
• In the operating room, the patient was found to have a
laceration to her adenoid pad close to the midline, which
was not visualized at the bedside.
• The patient was successfully weaned from ECMO the
following day and required no further blood transfusions
after this point.
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METHODS
A retrospective chart review was performed for all 
ECMO patients from July 2010 to July 2011. 
Incidence of upper aerodigestive tract bleeding 
that required an otolaryngology consultation was 
recorded. Their notes were further reviewed to 
determine location of bleed, chronological time 
line after instrumentation, and procedures 
performed to stop the bleeding. 
Our institution had 37 consecutive patients on 
ECMO from July 2010- July, 2012, of which 11 
(30%) had upper aerodigestive tract bleeding 
events.  
• Of these 11, 64% were secondary to an 
iatrogenic incident 
• 64% were from the nose or nasopharynx, 
36% were from the oropharynx
• Otolaryngology consultation was obtained 
within 12-18 hours
• All patients were anticoagulated with 
intravenous heparin at the time of the 
bleeding with an averaged PTT of 45secs 
(range 28-72).  Anticoagulation was initially 
held for 12-24 hours or longer.
• All patients underwent bedside ENT 
procedures including Oxymetolazone spray 
in 100% and Merocel packing in 73%.  
• Repeated bleeding after initial 
otolaryngology procedure was observed in 
36%.  
• Operative procedure was performed in 27% 
and none of them re-bled.  
Upper Aerodigestive Tract Bleeding
Nares:
Spray with Oxymetolazone
Pack with Merocel gauze
Oral Cavity:
Pack with Merocel gauze
Hold or lower anticoagulation
Limit instrumentation
Use softer suction catheters
Nasopharyngolaryngoscopy
Repeat NPL
Continue conservative management 
Operating Room for Hemostasis
24-36 hours total
Continued need for transfusions?
Persistent Bleed?
Persistent Bleed?
CONCLUSIONS
• In the ECMO patient, the incidence of upper 
aerodigestive tract bleeding was as high as 
30%. 
• Conservative management should be 
performed first, but  if bleeding continues for 
greater than 24-36 hours and the patient 
demonstrates continued blood transfusion 
requirements, surgical intervention may be 
necessary.  
Algorithm of upper aerodigestive tract bleeding in patient on ECMO.  
• If a patient develops upper aerodigestive tract bleeding, anticoagulation 
profiles should be reduced to 1.3-1.4 times aPTT, limited interventions 
should be performed and suctioning should be done with softer red rubber 
catheters rather than traditional nasotracheal suctioning devices
• If bleeding continues, NPL should be performed. Once bleeding is 
identified, Oxymetolazone and direct pressure via packing can be initiated.
• If conservative management fails to control the bleeding, the patient 
continues to require transfusions and it’s been longer than 24-36hrs, 
exploration in the operating room may be warranted. 
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